NEW YORK (GenomeWeb) – Becton Dickinson today reported a 5 percent jump in its third quarter revenues with growth across all three of its business segments.

The Franklin Lakes, NJ-based medical products, diagnostics, and research tools firm reported total revenues of $2.16 billion for the three months ended June 30, up from $2.05 billion for Q3 2013. It beat the average Wall Street estimate of $2.14 billion.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.